Press release
Peptic Ulcer Drugs In Global Market: North America to Lead in Global Market During The Forecast Period 2016 - 2022
Market Research Report
Peptic ulcer disease represents a group of ulcerative disorders such as gastritis, gastric ulcers, and duodenal ulcers or gastroesophageal reflux disease (GERD). Treatment of peptic ulcers is achieved through drugs such as proton pump inhibitors (PPI), potassium-competitive acid blockers (P-CAB), antacid, H2-antagonist, antibiotics, and ulcer protective drugs such as sucralfate. Increasing usage of non-steroidal anti-inflammatory drugs such as aspirin due to increasing inflammatory conditions is the major factor driving the growth of the global peptic ulcer drugs market. However, side effects of long-term use of PPIs, changing government policies, loss of market exclusivity of a majority of peptic ulcer drugs, and limited R&D efforts in the field of peptic ulcer drugs are factors expected to hamper the growth of peptic ulcer drugs market, globally.
The peptic ulcer drugs market is segmented as follows:
By Product Type
By Disease Indication
By Distribution Channels
By Region
This report covers the global peptic ulcer drugs market performance in terms of revenue contribution. The report includes key trends, drivers, restraints, and opportunities influencing the growth of the global peptic ulcer drugs market over the forecast period. Impact analysis of key growth drivers and restraints, based on the weighted average model, are included to provide clients with crystal clear decision-making insights.
Based on product type, the global peptic ulcer drugs market is segmented into proton pump inhibitors (PPI), potassium-competitive acid blockers (P-CAB), antacids, ulcer protective drugs, H2-antagonists, and antibiotics. The PPIs segment is expected to remain the dominant segment in terms of value during the forecast period.
By disease indication, the global peptic ulcer drugs market is segmented as gastritis, gastric ulcer, duodenal ulcer or gastroesophageal reflux disease (GERD). GERD segment is expected to dominate in terms of market share contribution, accounting for the maximum share of the overall market by 2022 end; whereas revenue from gastric ulcer segment is projected to expand at highest CAGR of during the forecast period.
On the basis of the distribution channel, hospital pharmacies segment is expected to hold maximum market share in the global market for peptic ulcer drugs.
By region, the market in North America is expected to lead in the global peptic ulcer drugs market. In 2014, North America and Europe collectively accounted for 67% share of overall marker revenue. Asia Pacific market accounted for 22% share in global peptic ulcer drugs market and is expected to gain significant market share over the forecast period, due to increasing recurrence of peptic ulcer disease. The MEA market is expected to witness sluggish growth during the forecast period partly due to low accessibility to peptic ulcer drugs in the region.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1287192
Key segments covered
Product Type
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers
Antacids
H2-antagonists
Antibiotics
Ulcer Protective Drugs
Disease Indication
Gastritis
Gastric Ulcer
Duodenal Ulcer
Gastroesophageal Reflux Disease (GERD)
Distribution Channel
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
e-Commerce
Key Regions/Countries Covered
North America
U.S.
Canada
Europe
Germany
Italy
France
U.K.
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Key features included in this report
Drivers and restraints of the peptic ulcer drugs market
Pipeline analysis and key developments in the market
Analysis of business strategies of key players
Peptic ulcer drugs market estimates and forecast
Key market players covered in this report include:
Daewoong Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Company Limited.
Pfizer Inc.
Abbott Laboratories.
AstraZeneca Plc.
Cadila Healthcare Ltd.
Boehringer Ingelheim GmbH.
Eisai Co. Ltd.
Yuhan Corporation.
GlaxoSmithKline Pharmaceuticals Ltd.
Other.
Browse More Details @ http://www.researchmoz.us/global-market-study-on-peptic-ulcer-drugs-north-america-to-lead-in-global-market-during-forecast-period-2016-2022-driven-by-increasing-nsaid-consumption-report.html
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptic Ulcer Drugs In Global Market: North America to Lead in Global Market During The Forecast Period 2016 - 2022 here
News-ID: 683735 • Views: …
More Releases for PPI
Pre Production Inspection (PPI) Market 2022: Industry Demands and Manufacturers …
The Pre Production Inspection (PPI) market research report brings into vital survey about market definition, market division, and severe examination on the lookout. The Pre Production Inspection (PPI) Market Research report contains a qualified and in-depth assessment of Pre Production Inspection (PPI) Industry. It considers the CAGR, value, volume, revenue, manufacture, utilization, sales, manufacturing cost, prices, and other key factors related to the global Pre Production Inspection (PPI) market. Documentation…
Global Optical Splitter Market 2018 - NTT Electronics, Senko, Wooriro, PPI
The statistical surveying information incorporated into the Optical Splitter report is the aftereffect of significant essential and optional research exercises. The report fragments the worldwide market for Optical Splitter based on makers, item compose, applications, and Region. In this report, each fragment is contemplated completely and measurements are introduced in detail. The report offers an exact outline of the worldwide Optical Splitter advertise covering key factors, for example, drivers and…
Global Industrial Casters Market 2017 : JARVIS, BLICKLE, PPI, TRIO-PINES, RWM Ca …
Industrial Casters
A market study based on the " Industrial Casters Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Industrial Casters Market 2017’. The research report analyses the historical as well as present performance of the worldwide Industrial Casters industry, and makes predictions on the future status of Industrial Casters market on the basis of this analysis.
Get Free Sample Copy of Report Here…
FSA Gives Banks Extension to Deal with 2011 PPI Claims
The Financial Services Authority (FSA) has given high street banks more time to deal with payment protection insurance (PPI) mis-selling claims.
The FSA has given banks
Under FSA rules PPI complaints have to be responded to within eight weeks.
The extension gives firms time to deal with claims which had been put on hold. It has also given more time for the firms to deal with PPI complaints received since the…
Mis-sold PPI - The Worst Personal Finance Scandal Ever?
New information released by the Financial Services Authority (FSA) could see mis-sold PPI become the worst ever personal finance scandal to hit Britain.
The FSA believes it will receive 2.75 million complaints about mis-sold PPI over the next five years. Compensation to the customers who have been mis-sold PPI policies is expected to top £4 billion.
Could mis-sold PPI become Britain's worst ever personal finance scandal? If the level of complaints…
PPI Most Complained About Financial Problem
FOR IMMEDIATE RELEASE
London, UK, 16th September, 2010: Payment Protection Insurance (PPI) was the most complained about financial issue in the first half of 2010, according to new figures.
The Financial Ombudsman Service (FOS) has received 30,000 complaints from consumers who have been mis-sold the policies.
The body received three times more complaints about PPI than the combined totals for mortgages, investments, and pensions.
Overall, 84,212 new complaints were made to the FOS about…
